|
|
|
| 13/10/08 |
So far so good, say company chiefs |
The Australian
Link |
| 25/09/08 |
Eine Spritze für mehr Bräune |
InStyle (Germany - October edition) |
| 23/09/08 |
Clinuvel launches new phase 2 |
Biotechnology News |
| 23/09/08 |
More light for Clinuvel |
Australian Life Scientist |
| 08/09/08 |
Going safely back into the biotech water |
Ethical Investor |
| 04/09/08 |
Clinuvel clears Absolute overhang |
Biotechnology News |
| 20/08/08 |
Drug trials revive interest in biotechnology sector |
Download |
| 08/08/08 |
Next Generation Clinuvel.com |
Download |
| 12/06/08 |
Ethics approval for sun drug in sunny Manchester |
BioTechnology News |
| 23/04/08 |
Clinuvel skin treatment dosages safe |
Business Spectator |
| 18/04/08 |
MoneyTV - Interview mit Dr. Philippe Wolgen, CEO von Clinuvel Pharmaceuticals |
MoneyTV (Germany)
Link |
| 17/04/08 |
Clinuvel steuert 2009 Zulassung für Hautpräparat an |
Euro am Sonntag (Germany) |
| 08/04/08 |
EMEA grants two orphan drug designations to Clinuvel |
BioSpectrum - Asia Edition |
| 17/03/08 |
TradeCentre
Ticker |
TradeCentre
Börsenbrief (Germany) |
| 14/03/08 |
Clinuvel Pharmaceuticals Successfully Changes Course With Regulators |
Bioshares |
| 13/03/08 |
Biotech corner |
The Australian |
| 13/03/08 |
Drug shines on a range of problems |
Herald Sun |
| 09/03/08 |
Web TV |
Cash Daily (Switzerland) |
| 01/03/08 |
Sonnige Aussichten |
Vogue (Germany) |
| 08/02/08 |
New drug may lead to a safer golden glow |
The Australian |
| 06/02/08 |
No magic bullet for biotech aspirants |
The Australian |
| 17/12/07 |
I've got you under my skin |
MXNews |
|
| Clinuvel Starts Skin Cancer Trials |
|
|
|
| Clinuvel Pharmaceuticals: "An excellent buying opportunity." |
|
|
|
| Clinuvel initiates Phase II skin cancer trials |
|
| Pharmaceutical Business Review |
|
|
| Tan pill hope for cancer fight |
|
|
|
|
| Side effect has all-over appeal |
|
|
|
|
|
|
| Clinuvel's Drug Begins Global Phase II Skin Cancer Trials |
|
|
| |
| Biotechs inject market spark |
|
|
|
| Clinuvel says cash freeze won't stop drug trial |
|
|
|
|
|
|
|
|
|
| Enigmatic drug keeps CEO on his toes |
| Biotech Daily's CEO interview |
|
|
